In glioma, aberrant expression of ADARB1 can affect the proliferation and invasion of glioma cells by regulating microRNAs (Cesarini et al., 2018) or CDC14B-Skp2 signaling axis (Galeano et al., 2013). The gene discussed is SKP2; the disease is central nervous system cancer.